Intracisternal octreotide does not ameliorate orthodromic trigeminovascular nociception

Cephalalgia

Volumn 20, Issue 2, 2000, Pages 114-121

  Kemper, R H A ^a   Jeuring, M ^a   Meijler, W J ^a   Korf, J ^a   Ter Horst, G J ^a,b  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

Capsaicin; Headache; Migraine; Somatostatin; Trigeminal

Indexed keywords

CAPSAICIN; OCTREOTIDE; SODIUM CHLORIDE; SOMATOSTATIN DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD BRAIN BARRIER; CONTROLLED STUDY; DRUG EFFECT; MALE; MIGRAINE; NOCICEPTION; NONHUMAN; RAT; SCRATCHING; TRIGEMINAL NERVE; TRIGEMINAL NUCLEUS; TRIGEMINUS NEURALGIA;

ANIMALS; CAPSAICIN; CISTERNA MAGNA; EXPLORATORY BEHAVIOR; MALE; OCTREOTIDE; PAIN MEASUREMENT; RATS; RATS, WISTAR; TRIGEMINAL NUCLEI; VASOCONSTRICTOR AGENTS;

EID: 0034454072     PISSN: 03331024     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1468-2982.2000.00031.x     Document Type: Article

References (51)

1. Distribution and origin of bombesin, substance P and somatostatin in cat spinal cord
2. Somatostatin
3. Pharmacodynamic effects of Sandostatin in the gastrointestinal tract
4. Octreotide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in conditions associated with excessive peptide secretion
5. Classification and nomenclature of somatostatin receptors
6. The two isoforms of the mouse somatostatin receptor (mSSTR2A and mSSTR2B) differ in coupling efficiency to adenylate cyclase and in agonist-induced receptor desensitization
7. mRNA distribution of two isoforms of somatostatin receptor 2 (mSSTR2A and mSSTR2B) in mouse brain
8. Pain relief by somatostatin in attacks of cluster headache
9. Treatment of migraine attacks with a long-acting somatostatin analogue (Octreotide SMS 201-995)
10. Efflux of taurocholic acid across the blood-brain barrier: Interaction with cyclic peptides
11. Somatostatin receptor imaging in intracranial tumours
12. Substance P in trigeminal nerve endings: Occurrence and release
13. Platelet substance P and 5-hydroxytryptamine in migraine and tension-type headache
14. Sensory neuropeptides (substance P, calcitonin gene-related peptide) and vasoactive intestinal polypeptide in human saliva: Their pattern in migraine and cluster headache
15. The neurobiology of vascular head pain
16. Neurotransmitters and the fifth cranial nerve: Is there a relation to the headache phase of migraine?
17. The nonpeptide neurokinin-1 antagonist, RPR 100893, decreases c-fos expression in trigeminal nucleus caudalis following noxious chemical meningeal stimulation
18. Evidence that substance P is a mediator of antidromic vasodilatation using somatostatin as a release inhibitor
19. Neurogenically mediated plasma extravasation in dura mater: Effect of ergot alkaloids. A possible mechanism of action in vascular headache
20. Ergot alkaloids block neurogenic extravasation in dura mater: Proposed action in vascular headaches
21. Indomethacin and acetylsalicylic acid block neurogenic plasma protein extravasation in rat dura mater
22. The antimigraine drug, sumatriptan (GR43175), selectively blocks neurogenic plasma extravasation from blood vessels in dura mater
23. UK-14,304, R (-) alpha-methyl-histamine and SMS 201-995 block plasma protein leakage within dura mater by prejunctional mechanisms
24. Anatomy of somatostatin-immunoreactive fibres and cell bodies in the rat trigeminal subnucleus caudalis
25. Ultrastructure of somatostatinimmunoreactive nerve terminals in laminae I and II of the rat trigeminal subnucleus caudalis
26. Distribution of somatostatin mRNA containing neurons in the primary pain relaying nuclei of the rat
27. Autoradiographic mapping of somatostatin receptors in the rat central nervous system and pituitary
28. Distribution of somatostatin receptors in the human brain: An autoradiographic study
29. Distribution of somatostatin receptors 1, 2 and 3 mRNA in rat brain and pituitary
30. Localization of somatostatin (SRIF) SSTR-1, SSTR-2 and SSTR-3 receptor mRNA in rat brain by in situ hybridization. Naunyn Schmiedebergs
31. Immunohistochemical localization of the somatostatin sst2 (b) receptor splice variant in the rat central nervous system
32. Is somatostatin or a somatostatin-like peptide involved in central nervous system control of gastric secretion?
33. Intrathecal somatostatin, somatostatin analogs, substance P analog and dynorphin A cause comparable neurotoxicity in rats
34. Somatostatin induced apnoea: Prevention by central and peripheral administration of the opiate receptor blocking agent naloxone
35. Central activation of the trigeminovascular pathway in the cat is inhibited by dihydroergotamine. A c-Fos and electrophysiological study
36. CP-93,129, sumatriptan, dihydroergotamine block c-fos expression within rat trigeminal nucleus caudalis caused by chemical stimulation of the meninges
37. Attenuation by valproate of c-fos immunoreactivity in trigeminal nucleus caudalis induced by intracisternal capsaicin
38. Naratriptan. Biological profile in animal models relevant to migraine
39. Inhibition of trigeminal neurons by intravenous administration of the serotonin (5HT)-1B/D receptor agonist zolmitriptan (311C90): Are brain stem sites therapeutics target in migraine?
40. Trigeminovascular stimulation in conscious rats
41. Ethical guidelines for investigations of experimental pain in conscious animals. Editorial
42. LPS induced hyperalgesia of intracranial capsaicin sensitive afferents in the conscious rat
43. Morphine and somatostatin analogue reduce cfos expression in trigeminal subnucleus caudalis produced by corneal stimulation in the rat
44. The NMDA receptor antagonist MK-801 reduces capsaicin-induced c-fos expression within rat trigeminal nucleus caudalis
45. Attenuation of Fos-like immunoreactivity in the trigeminal nucleus caudalis following trigeminovascular activation in the anaesthetised guinea-pig
46. Evidence for the participation of glutamate in reflexes involving afferent, substance P-containing nerve fibres in the rat
47. Interrelationships between somatostatin sst2a receptors and somatostatin-containing axons in rat brain: Evidence for regulation of cell surface receptors by endogenous somatostatin
48. Pain control with intrathecally and peridurally administered opioids and other drugs
49. Somatostatin receptor subtypes sst1 and sst2 elicit opposite effects on the response to glutamate of mouse hypothalamic neurons: An electrophysiological and single cell RT-PCR study
50. Novelty-induced increased expression of immediate-early genes c-fos and arg 3.1 in the mouse brain